Agenda & Registration
22nd ANNUAL ONCOLOGY RESEARCH & EDUCATION DAY
Rooms: SEI 1110 and Poster Rooms: SEI 4105 & 4106
Parking (FREE) Lot: Springlett Lot 1305 Western Road, lot south of Huron College
Thursday June 18, 2026 - 8:00AM to 4:30PM
REGISTER HERE
AGENDA
Overall Learning Objectives:
By the end of this program, participants will be able to:
1.To review new contributions from medical oncology, surgery, radiation oncology and medical biophysics, as well as advanced comprehensive cancer care; 2.Discuss and assess cutting-edge research in oncology, including novel methodologies for studying cancer at the cellular/molecular level and the implications for treatment and patient care; 3.Appraise research findings and demonstrate how collaboration can bridge clinical and basic science research in oncology.
| 8:00 |
Registration - SEI Lobby Please register and enjoy coffee/tea while networking with colleagues |
| 8:30 |
Welcome and Opening Remarks - SEI 1110 Lorin Dodbiba MD FRCPC and Len Luyt PhD - Conference Co-Chairs Michael Ott MD FRCSC - Department of Oncology Chair and Physician Executive Oncology LHSC |
| 8:45-9:45 |
Morning Oral Presentation - SEI Room 1110 Judges: Glenn Bauman MD FRCPC - Vice Dean - Clinical Affairs, Schulich School of Medicine & Dentistry, Western University. Peter J. H. Scott PhD - Paul L. Carson Collegiate Professor of Radiology, University of Michigan Silvia Penuela PhD - Assistant Dean - Translational Research, Schulich School of Medicine & Dentistry, Western University. |
| 8:45 | 1. |
| 9:00 | 2. |
| 9:15 | 3. |
| 9:30 | 4. |
| 9:45-11:45 | POSTER AND NETWORKING SESSION - SEI Room 4105 & 4106
Poster viewing and judging Please enjoy refreshments and light snack Please visit the sponsor booths located around the perimeter |
| 11:45-12:15 |
Talk: SEI 1110The Evolving Landscape of Theranostics in London and CanadaObjectives: By the end of this session, participants will be able to describe the current theranostics and imaging programs operating in London; participants will appraise the translational nature of theranostics activities in London including imaging; participants will be able to infer the role of London scientist and clinicians in the implementation of theranostics in Canada.Michael S. Kovacs PhD - Imaging Program Leader, Lawson Research Institute at St. Joseph's Health Care London Ryan MacDonald MBA CHE BSc MRT(NM) - Director, Medical Imaging, London Health Sciences Centre Mina Swiha MBBCh PhD FRCPC ABNM - Clinician, Molecular Imaging & Theranostics Stephen Nelli MBA CHE BSc MRT(N) - Director, Medical Imaging & Breast Care, St. Joseph's Health Care London
|
| 12:15-1:15 |
Keynote Lecture - SEI 1110 "Theranostics - New Developments in Precision Cancer Care that are Transforming Patient Prognosis" Peter J. H. Scott PhD. Paul L. Carson Collegiate Professor of Radiology, University of Michigan | Cross appointed to Department of Medicinal Chemistry and Pharmacology | Director, PET Center | Associate Chair for Basic Science Research | Division Director, Nuclear MedicineChair | Radiation Policy Committee Co-Chair | Radioactive Drug Research Committee Objectives: Summarize the history of theranostics that defined the field today; List the theranostics approved by FDA for treatment of neuroendocrine tumors and metastatic prostate cancer; Describe emerging theranostics that are in advanced clinical trials around the world; Demonstrate how dosimetry and theranostics can be applied in personalized cancer care. |
| 1:15-2:15 |
Lunch - SEI 1110 |
| 2:15-3:15 |
Afternoon Oral Presentations - SEI Room 1110 Judges: Glenn Bauman MD FRCPC - Vice Dean - Clinical Affairs, Schulich School of Medicine & Dentistry, Western University. Peter J. H. Scott PhD - Paul L. Carson Collegiate Professor of Radiology, University of Michigan Silvia Penuela PhD - Assistant Dean - Translational Research, Schulich School of Medicine & Dentistry, Western University. |
| 2:15 |
5. |
| 2:30 | 6. |
| 2:45 | 7. |
| 3:00 | 8. |
| 3:15-3:45 |
Panel Discussion - SEI 1110 Experimental Agents for the Future Moderator: Lorin Dodbiba MD Objectives: By the end of this session, participants will be able to describe the future of cancer therapeutics; Participants will be able to differentiate between various novel experimental agents; and participants will be able to critique the various approaches being investigated for cancer therapy including imaging. Panelists: Ricardo Fernandes MD - Medical Oncologist and Fellowship Director David Laidley MD - Molecular Imaging and Theranostics Physician Jacques Raphael MD - Medical Oncologist and Director, Baines Centre Peter J. H. Scott PhD - Chemist and Radiochemist |
| 3:45-4:30 |
Presentation of Awards - SEI 1110 Michael Ott - Department of Oncology, Excellence in Academic and Teaching Awards (5) Glenn Bauman - Centre for Translational Cancer Research, Graduate Trainee Excellence Awards (2) Morgan Black - Denise Power Cancer Research Staff Award of Excellence (1) Lorin Dodbiba and Len Luyt - Oral (2) and Poster Presentation Awards (10) |
| 4:30 |
Concluding Remarks and Adjournment Lorin Dodbiba and Len Luyt |
*25% of this program is dedicated to participant’s interaction.
* This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by Continuing Professional Development, Schulich School of Medicine & Dentistry, Western University. You may claim a maximum of xxx hours (credits are automatically calculated).
*This program has received an educational grant or in-kind support from: Gold Sponsors: AstraZeneca, Johnson and Johnson, Knight Therapeutics, and Novartis. Silver Sponsors: AbbVie, Astellas, Bayer, BeOne Medicines (Canada), Bristol Myers Squibb, Daiichi Sankyo, Eisai, EMD Serono, GSK, Ipsen, Lilly, Medison Pharma, Merck, Pfizer. Bronze Sponsors: Roche, Servier, Takeda
